OĞUL, A. Et Al. 2017. The Importance of Parameters: MPV, MPV/Thrombocyte Ratioand Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer. 1. Çukurova Hepatoselüler Karsinoma Sempozyumu , (Turkey).

OĞUL, A., ŞAHİN, B., KUŞÇU, F., TAKTAKOĞLU, O., YETİŞİR, A. E., BÜYÜKŞİMŞEK, M., ... MİRİLİ, C.(2017). The Importance of Parameters: MPV, MPV/Thrombocyte Ratioand Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer . 1. Çukurova Hepatoselüler Karsinoma Sempozyumu, Turkey

OĞUL, ALİ Et Al. "The Importance of Parameters: MPV, MPV/Thrombocyte Ratioand Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer," 1. Çukurova Hepatoselüler Karsinoma Sempozyumu, Turkey, 2017

OĞUL, ALİ Et Al. "The Importance of Parameters: MPV, MPV/Thrombocyte Ratioand Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer." 1. Çukurova Hepatoselüler Karsinoma Sempozyumu , Turkey, 2017

OĞUL, A. Et Al. (2017) . "The Importance of Parameters: MPV, MPV/Thrombocyte Ratioand Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer." 1. Çukurova Hepatoselüler Karsinoma Sempozyumu , Turkey.

@conferencepaper{conferencepaper, author={ALİ OĞUL Et Al. }, title={The Importance of Parameters: MPV, MPV/Thrombocyte Ratioand Neutrophil/Lymphocyte Ratio in Sorafenib Treatment Response of Patients with Hepatocellular Cancer}, congress name={1. Çukurova Hepatoselüler Karsinoma Sempozyumu}, city={}, country={Turkey}, year={2017}}